Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS · NASDAQ Global Select
+$0.02 today
Vol 0.70M · Avg 0.40M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+83.74%
Period High
$3.37
Period Low
$1.11
Latest
$2.26
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$335.63M
Fate Therapeutics, Inc.
NASDAQ:FATE
$230.20M
Alector, Inc.
NASDAQ:ALEC
$182.64M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$126.51M
Agenus Inc.
NASDAQ:AGEN
$123.26M
Seer, Inc.
NASDAQ:SEER
$94.57M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$61.98M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.15M
Actuate Therapeutics Inc
NASDAQ:ACTU
$51.44M
VistaGen Therapeutics, Inc.
VTGN
$22.73M
What is the latest ABOS filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does ABOS have?
Intrinsic Alpha currently shows 20 recent filings for ABOS.
Explore More
Continue the stock analysis
Jump to another research area for this company.